Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
Beat M Kuenzli, Maria-Isabell Bernlochner, Stephan Rath, Samuel Kaeser, Eva Csizmadia, Keiichi Enjyoji, Peter Cowan, Anthony d'Apice, Karen Dwyer, Robert Rosenberg, Aurel Perren, Helmut Friess, Christoph A Maurer, Simon C Robson
Purinergic Signalling | SPRINGER | Published : 2011
Awarded by German Research Foundation (DFG)
Awarded by National Institute of Health (NIH)
We would like to thank Dr. Kirk Ives and Dr. CM Townsend (UTMB, Galveston, USA) for their support in the present study and for providing our institution with the MC-26 mouse colorectal cancer cell line. Grants-this work was supported by the German Research Foundation Grants (DFG KU 1957/1-1 and DFG KU 1957/3-1 to B. M. K.) and the National Institute of Health (NIH HL63972 and HL076540 to S.C.R).